Scinai Immunotherapeutics (SCNI) Change in Working Capital (2020)
Scinai Immunotherapeutics' (SCNI) quarterly Change in Working Capital came in at -$1.6 million in Q4 2020, down 230.4% quarter-over-quarter from $1.2 million in Q3 2020.
Scinai Immunotherapeutics (SCNI) Change in Working Capital (2020) Analysis & Trends
Scinai Immunotherapeutics has disclosed Change in Working Capital across 1 years of filings, most recently posting -$1.6 million for Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -1.61 Mn |
| Dec 31, 2020 | -1.61 Mn |
| Sep 30, 2020 | 1.24 Mn |
| Sep 30, 2020 | 1.24 Mn |